FDA.reportPublic FDA data

GANCICLOVIR SODIUM

Substance profile for UNII 02L083W284, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for GANCICLOVIR SODIUM
Structure render from NCI/CADD chemical resolver

Substance Identity#

UNII
02L083W284
Preferred term
GANCICLOVIR SODIUM
Registry number
107910-75-8
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C9H12N5O4.Na
Chemical structure for GANCICLOVIR SODIUM
Structure render from NCI/CADD chemical resolver

Chemical And Database Identifiers#

InChIKey
JJICLMJFIKGAAU-UHFFFAOYSA-M
SMILES
[Na+].NC1=NC2=C(N=CN2COC(CO)CO)C(=O)[N-]1
RxCUI
82131
PubChem
0
NCIt
C1588
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem InChIKey SearchJJICLMJFIKGAAU-UHFFFAOYSA-Mhttps://pubchem.ncbi.nlm.nih.gov/#query=JJICLMJFIKGAAU-UHFFFAOYSA-M
RxNorm82131https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=82131
NCI ThesaurusC1588https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1588
FDA Substance Registration System02L083W284https://precision.fda.gov/uniisearch/srs/unii/02L083W284

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ganciclovir sodiumACTIVE INGREDIENT02L083W284CYTOVENE IV (GANCICLOVIR SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GENENTECH, INC.]6
GANCICLOVIR SODIUMACTIVE INGREDIENT02L083W284GANCICLOVIR (GANCICLOVIR SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]2
GANCICLOVIR SODIUMACTIVE INGREDIENT02L083W284GANCICLOVIR (GANCICLOVIR SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC]1